For the year ending 2025-12-31, VNDA made $216,105K in revenue. -$220,474K in net income. Net profit margin of -102.02%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenues | 216,105 | |||
| Cost of goods sold excluding amortization | 13,044 | |||
| Research and development | 109,271 | |||
| Selling, general and administrative | 237,951 | |||
| Intangible asset amortization | 7,007 | |||
| Total operating expenses | 367,273 | |||
| Loss from operations | -151,168 | |||
| Other income, net | 12,521 | |||
| Income (loss) before income taxes | -138,647 | |||
| Provision (benefit) for income taxes | 81,827 | |||
| Net income (loss) | -220,474 | |||
| Basic (in dollars per share) | -3.74 | |||
| Basic (in shares) | 58,930,157 | |||
| Diluted (in dollars per share) | -3.74 | |||
| Diluted (in shares) | 58,930,157 | |||
Vanda Pharmaceuticals Inc. (VNDA)
Vanda Pharmaceuticals Inc. (VNDA)